cRGD-ZW800-1

N/A

Report date: 2026/01/09 10:04:37
NME

Base Information

Drug NamecRGD-ZW800-1
Drug Alias NameNIR fluorescent peptide（Curadel）Cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1cRGD-ZW800-1CPI-008
ClassificationSmall molecules > Synthetic peptideDiagnostic agent (In vivo)
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsSquamous Cell Carcinoma of Head and NeckCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCuradel
China Registration ClassN/A

Develop Information

Active CompaniesCuradelLeiden University Medical Center
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsSquamous Cell Carcinoma of Head and NeckCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A